Delivery Order SPE2DB25D3110-SPE2DB26FTCCD
- Not listed
- The Defense Logistics Agency awarded a $1,748.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (8-count packaging). The delivery order, which concludes on September 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made through open...
- The Defense Logistics Agency awarded a delivery order valued at $1,285.89 to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (8-count package) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,073.04 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on May 20, 2025, with completion scheduled for May 21, 2025. This contract was awarded on a firm fixed-price basis without set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,616.29 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count package) on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $1,297.42 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (8-count package) on April 24, 2025, with an ultimate completion date of April 25, 2025. This competitive award, issued without set-aside designation, reflects a firm fixed-price delivery order for pharmaceutical supply. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a $1,967.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 count) on September 8, 2025, with completion targeted for September 9, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on September 15, 2025, for Yuvafem 10 mcg vaginal inserts (18-count package). This is a firm fixed-price delivery order with a ceiling value of $1,616.52, with an ultimate completion date of September 16, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,163.80 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The awardee, AmerisourceBergen Drug Corp, is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and the place of performance is also located in...
- The Defense Logistics Agency awarded a delivery order valued at $1,145.73 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on August 13, 2025, with completion scheduled for August 14, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, procured through open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,937.84 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on September 29, 2025, with completion targeted for September 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB26FTCCDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,115.12 to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18-count). The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award through open competition. Performance will be executed from the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 20, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's DLA contract vehicle enables supply of a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Yuvafem demonstrates the company's role in supplying specialized pharmaceutical products within the broader DLA Pharmaceutical Prime Vendor Global Program structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 10/17/25 |